A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies

T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatly expanded donor availability and are increasingly utilized. Haplo were originally performed using truly nonmyeloablative conditioning and a bone marrow graft. We have also developed myeloablative con...

Descripción completa

Detalles Bibliográficos
Autores principales: Solh, Melhem M., Hinojosa, Gabriel, Laporte, Justin, Solomon, Scott R., Morris, Lawrence E., Zhang, Xu, Holland, H. Kent, Bashey, Asad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009703/
https://www.ncbi.nlm.nih.gov/pubmed/33859695
http://dx.doi.org/10.1155/2021/8868142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009703/
https://www.ncbi.nlm.nih.gov/pubmed/33859695
http://dx.doi.org/10.1155/2021/8868142

Ejemplares similares